Main Menu

Making the discoveries that defeat cancer

The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. Please see the latest updates concerning our response to coronavirus.

Study sheds light on genetic basis of Black men’s higher prostate cancer risk

Black men are more likely than their White or Asian counterparts to have a range of genetic changes that increase their risk of developing prostate cancer, a major new study reports.
Read more
Help us bring hope to children with cancer

Support our new research programme using revolutionary laboratory models to bring fresh hope to children with cancer.
Donate now
The BRCA2 team: Researchers behind the breast cancer gene discovery

25 years ago, ICR researchers made a historic discovery, here are some of their stories.
Read more

1/3

Smarter, kinder treatments

We will move a step closer to cure by bringing personalised treatments into the clinic and developing them for patients.
Personalised treatments
Making it count

We will deliver better outcomes and quality of life for patients by establishing innovative treatments, diagnostics and prevention strategies as part of routine healthcare.
Improving patient lives
Unravelling cancer’s complexity

We will comprehend the full complexity of cancer by harnessing the power of new technologies and Big Data.
Big data research
Innovative approaches

We will take on the challenge of cancer’s complexity, evolution and drug resistance through the discovery of innovative new approaches to cancer treatment.
Our innovative approaches
Creating new treatments that target tumours

Teams of biologists, chemists and computational scientists design new drugs to selectively attack tumours.
About drug discovery
Queen's Anniversary Prize

The ICR has been recognised with a prestigious Queen’s Anniversary Prize for its world-leading research in cancer drug discovery.
Queen's Anniversary Prize